E. Ubiña Aznar

593 total citations
12 papers, 282 citations indexed

About

E. Ubiña Aznar is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, E. Ubiña Aznar has authored 12 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in E. Ubiña Aznar's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). E. Ubiña Aznar is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). E. Ubiña Aznar collaborates with scholars based in Spain, France and Palestinian Territory. E. Ubiña Aznar's co-authors include E Soriano, José Mallolas, Ana Guelar, José M. Gatell, Estebán Martínez, Luisa Seco Lozano, José M. Miró, Laura Zamora, J. González and Gregorio García Fernández and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and AIDS.

In The Last Decade

E. Ubiña Aznar

12 papers receiving 263 citations

Peers

E. Ubiña Aznar
Comparison fields: 5 of 44
  • Epidemiology 217
  • Infectious Diseases 167
  • Surgery 107
  • Virology 38
  • Immunology 21
Replace Nagalingeswaran Kumarasamy with:
Nagalingeswaran Kumarasamy India
M. Schechter United States
Jorge Francisco da Cunha Pinto Brazil
Renee Weinman United States
Aikichi Iwamoto Japan
S M Forster United Kingdom
Paulo S. Silveira-Mattos Brazil
Hulya Levendoglu United States
J. Weel Netherlands
Paolo Troia-Cancio United States
Nagalingeswaran Kumarasamy India View profile →
Citations per field, relative to E. Ubiña Aznar
E. Ubiña Aznar · 1×
Citations per year, relative to E. Ubiña Aznar
E. Ubiña Aznar · 1×

Countries citing papers authored by E. Ubiña Aznar

Since Specialization
Citations

This map shows the geographic impact of E. Ubiña Aznar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ubiña Aznar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ubiña Aznar more than expected).

Fields of papers citing papers by E. Ubiña Aznar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Ubiña Aznar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ubiña Aznar. The network helps show where E. Ubiña Aznar may publish in the future.

Co-authorship network of co-authors of E. Ubiña Aznar

This figure shows the co-authorship network connecting the top 25 collaborators of E. Ubiña Aznar. A scholar is included among the top collaborators of E. Ubiña Aznar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Ubiña Aznar. E. Ubiña Aznar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
# Work Indexed citations
1 6
2 1
3 8
4 2
5 2
6 2
7
[Systemic arterial hypertension in primary chronic glomerulonephritis: prevalence and its influence on the renal prognosis].
3
8 103
9 5
10 142
11
Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection. Spanish Ribavirin Trial Group.
3
12 5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026